azauridine has been researched along with Experimental Mammary Neoplasms in 2 studies
Azauridine: A triazine nucleoside used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holstege, A | 1 |
| Keppler, D | 1 |
| Nowak, C | 1 |
| Elbe, B | 1 |
| Arnold, W | 1 |
| Bender, E | 1 |
2 other studies available for azauridine and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Effects of D-glucosamine and 6-azauridine on nucleotide contents, 5-fluorouridine uptake, and cytotoxicity in TA3 mammary tumor cells.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Combined Chemotherapy Protocols; Azauridine; Cytidin | 1986 |
[Influence of cyclophosphamide, ribo-azauracil and mercaleukin pretreatment on experimental metastasizing in a syngenic tumor-host system. I. Spontaneous breast carcinoma of the mouse].
Topics: Animals; Azauridine; Cyclophosphamide; Female; Male; Mammary Neoplasms, Experimental; Mercaptopurine | 1973 |